Annual Drug Patent Expirations for TRILEPTAL Trileptal is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There is one patent protecting…
The post New patent expiration for Novartis drug TRILEPTAL appeared…
New patent expiration for Novartis drug TRILEPTAL Read Post »
OSENI (alogliptin benzoate; pioglitazone hydrochloride) Takeda pharms usa Patent: 6,329,404 Expiration: Jun 19, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent Ex…
Drug Patent Expirations for the Week of June 13, 2021 Read Post »
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Xspire Pharma drug ZONTIVITY appeared …
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
Annual Drug Patent Expirations for INTELENCE Intelence is a drug marketed by Janssen R And D and is included in one NDA. It is available from one supplier. There is…
The post New patent expiration for Janssen R drug INTELENCE appeared first on DrugPate…
New patent expiration for Janssen R drug INTELENCE Read Post »
FYCOMPA (perampanel) Eisai inc Patent: 6,949,571 Expiration: Jun 8, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Ex…
Drug Patent Expirations for the Week of June 6, 2021 Read Post »
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Eisai Inc and is included in two NDAs. It is available from one supplier. There are two patents…
The post New patent expiration for Eisai Inc drug FYCOMPA appeared first on DrugPa…
New patent expiration for Eisai Inc drug FYCOMPA Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent expiration for Cumberland Pharms drug VIBATIV appear…
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
Annual Drug Patent Expirations for QUTENZA Qutenza is a drug marketed by Averitas and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Averitas drug QUTENZA appeared fi…
Annual Drug Patent Expirations for CARAC Carac is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from three suppliers. There is one…
The post New patent expiration for Valeant Pharms drug CARAC appeared first on Dru…
New patent expiration for Valeant Pharms drug CARAC Read Post »
VIBATIV (telavancin hydrochloride) Cumberland pharms Patent: 6,872,701 Expiration: Jun 5, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The …
Drug Patent Expirations for the Week of May 30, 2021 Read Post »